Cargando…
USING QT INTERVAL AS A PREDICTOR OF ILLNESS ACUITY DUE TO COVID-19
Autores principales: | Vangala, Adarsh S., Myla, Madhura, Harkins, Michelle, Sheldon, Mark W., Raizada, Veena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982909/ http://dx.doi.org/10.1016/S0735-1097(23)00515-6 |
Ejemplares similares
-
HYDROXYCHLOROQUINE ATTENUATES HERG CHANNEL BY PROMOTING THE MEMBRANE CHANNEL DEGRADATION: EVIDENCES FOR QT-INTERVAL PROLONGATION IN COVID-19 PATIENTS WITH HYDROXYCHLOROQUINE TREATMENT
por: Wang, Xiqiang, et al.
Publicado: (2022) -
Interval‐based features of auditory ERPs for diagnosis of early Alzheimer's disease
por: Sabbaghi, Neda, et al.
Publicado: (2021) -
LONG QTC AND VENTRICULAR TACHYCARDIA STORM DUE TO ACUTE COVID19 INFECTION
por: Saleem, Muhammad Sabih, et al.
Publicado: (2023) -
Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes
por: El-Sherif, Nabil, et al.
Publicado: (2019) -
SINUS BRADYCARDIA AS THE INITIAL MANIFESTATION OF COVID-19
por: Mendoza, Ivan, et al.
Publicado: (2021)